Bio-Rad Laboratories, Inc. BIO is scheduled to release second-quarter 2024 results on Aug 1, after the closing bell. The company posted adjusted earnings per share (EPS) of $2.29 in the last reported ...
May 7 (Reuters) - Diagnostics firm Bio Rad Laboratories (BIO.N), opens new tab reiterated its 2024 sales growth forecast on Tuesday, weighed by persistently weak spending by biotech companies and ...
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for ...
Aug 1 (Reuters) - Bio-Rad Laboratories (BIO.N), opens new tab cut its annual revenue growth forecast on Thursday, dragged down by weak demand for clinical diagnostics products from biotech clients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results